These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2363856)

  • 41. Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
    de Vries MR; ten Hagen TL; Marinelli AW; Eggermont AM
    Anticancer Res; 2003; 23(2C):1811-23. PubMed ID: 12820463
    [No Abstract]   [Full Text] [Related]  

  • 42. Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
    Feleszko W; Lasek W; Gołab J; Jakóbisiak M
    Neoplasma; 1995; 42(2):69-74. PubMed ID: 7617079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
    Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
    Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M
    Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant tumor necrosis factor reduces hepatic drug metabolism in vivo in the rat.
    Duan L; Ghezzi P; Conti I; Tridico R; Bianchi M; Caccia S
    J Biol Response Mod; 1988 Aug; 7(4):365-70. PubMed ID: 3171600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
    Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
    Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models.
    Jiang C; Niu J; Li M; Teng Y; Wang H; Zhang Y
    PLoS One; 2014; 9(1):e87036. PubMed ID: 24466321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines.
    Gapany M; Dawson DE; Schriever C; Burgess R; Gipple JR; Riggs CE
    Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):436-9. PubMed ID: 2317326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery.
    Chen JH; Ling R; Yao Q; Wang L; Ma Z; Li Y; Wang Z; Xu H
    World J Gastroenterol; 2004 Jul; 10(13):1989-91. PubMed ID: 15222053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of acute necrosis in Walker 256 tumors in rats.
    Orvoine RH; Seidman JM
    Cancer Res; 1977 Jan; 37(1):102-5. PubMed ID: 830398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The evaluation of metastatic damage of the liver of the Wistar rats under conditions of spontaneous development of the Walker 256 carcinosarcoma].
    Kunts TA; Efremov AV; Ovsianko EV; Pustovetova MG
    Vopr Onkol; 2014; 60(1):80-3. PubMed ID: 24772621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)].
    Trashkov AP; Vasil'ev AG; Kovalenko AL; Petrov AY; Valeev VV
    Eksp Klin Farmakol; 2016; 79(2):34-9. PubMed ID: 27416681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An in vivo assessment of adriamycin-loaded albumin microspheres.
    Goldberg JA; Willmott N; Kerr DJ; Sutherland C; McArdle CS
    Br J Cancer; 1992 Mar; 65(3):393-5. PubMed ID: 1558792
    [No Abstract]   [Full Text] [Related]  

  • 57. Injection of recombinant tumor necrosis factor directly into liver metastases: an experimental and clinical approach.
    IJzermans JN; Scheringa M; van der Schelling GP; Geerling RA; Marquet RL; Jeekel J
    Clin Exp Metastasis; 1992 Mar; 10(2):91-7. PubMed ID: 1537138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents.
    Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich LI; Shvets YV; Lukyanova NY; Todor IM; Tregubova NA; Naleskina LA
    Ukr Biochem J; 2016; 88(1):99-108. PubMed ID: 29227592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of antitumor activity of antibodies to TNF-α on Walker carcinosarcoma model.
    Yurlova EI; Krylova SG; Dugina JL; Epstein OI
    Bull Exp Biol Med; 2013 Sep; 155(5):673-5. PubMed ID: 24288736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of local sclerosing therapy in the treatment of Walker 256 carcinosarcoma implanted in the liver].
    De Macedo AR; Faifer JG; Hossne WS
    Chir Patol Sper; 1979 Oct; 27(5):444-55. PubMed ID: 261944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.